Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2003
12/18/2003CA2487413A1 Methods of treating angiogenesis, tumor growth, and metastasis
12/18/2003CA2486491A1 4-(aryl or heteroaryl)-2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003CA2486362A1 Novel recombinant anticoagulant proteins
12/18/2003CA2485709A1 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor
12/18/2003CA2483555A1 Gamma lactams as prostaglandin agonists and use thereof
12/17/2003EP1371650A1 Activator for peroxisome proliferator-activated receptor
12/17/2003EP1371647A2 Pyridine-3-carboxylic acid derivatives and their use as intermediates
12/17/2003EP1371646A1 Aryl-substituted alicyclic compound and medical composition comprising the same
12/17/2003EP1371370A1 Drugs containing reduced vitamin b2
12/17/2003EP1371289A1 Choline-silicic acid complex
12/17/2003EP1370685A2 Diagnosis of diseases associated with dna repair
12/17/2003EP1370659A2 Proteins, polynucleotides encoding them and methods of using the same
12/17/2003EP1370655A2 Secreted human proteins
12/17/2003EP1370587A2 Antiangiogenic peptides derived from endostatin
12/17/2003EP1370586A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370584A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370568A1 Chemical compounds
12/17/2003EP1370562A1 Thieno[2,3-d]pyrimidindione derivatives as matrix metalloproteinase inhibitors
12/17/2003EP1370561A2 Tetrahydro-pyrazino[1,2-a]indoles for the treatment of central nervous disorders
12/17/2003EP1370560A1 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists
12/17/2003EP1370559A1 Triazolopyridines as anti-inflammatory agents
12/17/2003EP1370556A1 Metalloproteinase inhibitors
12/17/2003EP1370554A1 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
12/17/2003EP1370553A2 Rho-kinase inhibitors
12/17/2003EP1370552A2 Rho-kinase inhibitors
12/17/2003EP1370548A1 P-thienylbenzyl-amides serving as agonists of angiotensin-(1-7)-receptors, method for the production thereof, their use and pharmaceutical preparations containing the same
12/17/2003EP1370547A1 Benzoaxathiepin derivatives and their use as medicines
12/17/2003EP1370546A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
12/17/2003EP1370544A1 Nitric oxide donors based on metallic centres
12/17/2003EP1370542A1 Bicyclic guanidine derivatives and therapeutic uses thereof
12/17/2003EP1370540A1 Anti-thrombotic carboxylic acid amides, the production thereof and use of the same as medicaments
12/17/2003EP1370538A1 Metalloproteinase inhibitors
12/17/2003EP1370537A1 Metalloproteinase inhibitors
12/17/2003EP1370536A1 Metalloproteinase inhibitors
12/17/2003EP1370535A1 Metalloproteinase inhibitors
12/17/2003EP1370534A1 Metalloproteinase inhibitors
12/17/2003EP1370533A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
12/17/2003EP1370531A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors
12/17/2003EP1370530A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/17/2003EP1370528A1 Mch antagonists and their use in the treatment of obesity
12/17/2003EP1370527A1 Indolone derivatives having vascular-damaging activity
12/17/2003EP1370526A1 Diamides which inhibit tryptase and factor xa activity
12/17/2003EP1370523A1 Diphenyl derivatives
12/17/2003EP1370522A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
12/17/2003EP1370521A1 Formanilide derivatives as beta2-adrenoreceptor agonists
12/17/2003EP1370282A2 Method for treating ischemic events affecting the central nervous system
12/17/2003EP1370276A2 Medical uses of intercellular communication facilitating compounds
12/17/2003EP1370274A1 Compositions comprising matrine and dictamnine for treating or preventing cancer and other diseases
12/17/2003EP1370271A2 A process for the manufacture of a herbal composition comprising a matrine
12/17/2003EP1370267A2 Use of propentofylline to control intraocular pressure
12/17/2003EP1370260A2 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
12/17/2003EP1370256A1 Novel inhibitors of formation of advanced glycation endproducts (ages)
12/17/2003EP1370250A2 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
12/17/2003EP1370245A1 Method to prepare microparticles metoprolol that contain
12/17/2003EP1370211A2 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
12/17/2003EP1370148A1 Anticholesterolemic edible oil
12/17/2003EP1370144A1 Noninvasive measurements of chemical substances
12/17/2003EP1272470B1 Amorphous torasemide modification
12/17/2003EP1246825B1 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof
12/17/2003EP1226131B1 Isoxazolecarboxamide derivatives
12/17/2003EP1206467B1 N-heterocyclic derivatives as nos inhibitors
12/17/2003EP1189889B1 Compositions and methods for inhibiting cell death
12/17/2003EP1162970B1 Anti-inflammatory uses of manzamines
12/17/2003EP1147121B1 Ketolide antibiotics
12/17/2003EP1109799B1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors
12/17/2003EP1100775B1 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same
12/17/2003EP1082302B1 A vla-4 inhibitor: omepupa-v
12/17/2003EP0641218B1 Use of angiotensin antagonist (at1) for reducing post myocardial infarct mobidity and mortality
12/17/2003CN1462276A Peptide-based compounds
12/17/2003CN1462268A Substituted cinnamic acid guanidides, method for the production thereof, their use as medicament, and medicine containing these compounds
12/17/2003CN1462191A Treatment of ocute coronary syndrome with GLP-1
12/17/2003CN1461754A Telerance starch made of starch of de-amylopectin by iso-anylase
12/17/2003CN1461656A Medicinal excipient-potassium alginate and its composition
12/17/2003CN1461648A Medicine for treating various kinds of fistulas and pilesand anal fistula
12/17/2003CN1461645A 鳄鱼油丸 Crocodile oil pills
12/17/2003CN1131224C Luteolin and method for preparationg luteolin derivatives
12/17/2003CN1131222C Benzamide derivs and their use as APOB-100 secretion inhibitors
12/17/2003CN1131211C Heteraryl diazacy cloa lkanes as cholinergic ligands at nicotinic acetylcholine receptors
12/17/2003CN1131065C Medicine for treating hemipara lysis, obstruction of qi in the chest and cardialgia
12/17/2003CN1131061C Prepn. method for medicine liquid for treating piles
12/17/2003CN1131054C Chinese herbal medicine for treating hypertension
12/17/2003CN1131048C Medicine for treating blood vessel of heart and brain and preparation method thereof
12/17/2003CN1131043C Medicine for treating cardiovascular disease and its preparing process
12/17/2003CN1131031C Use of 4-phenyl-3,6-dihydro-2H-pyridyl derivatives for NMDA receptor subtype blockers
12/16/2003US6664420 For therapy of hypertension, type 2 insulin-resistant diabetes mellitus, ecalmpsia and preeclampsia
12/16/2003US6664395 Benzotriazole compoundsn are the potent inhibitors of MAP kinases, preferably p38 kinase. They are useful for treating inflammation, osteoarthritis, rheumatoid arthritis, cancer, reperfusion, ischemia
12/16/2003US6664393 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
12/16/2003US6664273 Having at least cyanobenzyl and amidobenzyl substituents; obesity, metabolic disorders, eating disorders such as hyperphagia and diabetes
12/16/2003US6664256 Interleukin- 1 beta inhibitors
12/16/2003US6664255 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/16/2003US6664230 Orally administered peptides to ameliorate atherosclerosis
12/16/2003US6664229 Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72
12/16/2003US6664227 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
12/16/2003US6664105 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
12/16/2003US6663900 Processed in a fluidized bed coating machine where a protective coating of a sugar or polyhydric alcohol, starch
12/16/2003US6663878 Anti-inflammatory bioactive glass particulates
12/16/2003US6663863 Method of inhibiting stenosis and restenosis
12/16/2003CA2275299C Indane or dihydroindole derivatives
12/16/2003CA2124578C A mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses
1 ... 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 ... 1595